Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Y Slaney

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2015
Releasing the Brake on Oncolytic Viral TherapyClare Y Slaney, Phillip K Darcy
Cancers|October 31, 2020
Challenges and Opportunities for Effective Cancer ImmunotherapiesClare Y Slaney, Michael H Kershaw
Cancer Research|September 25, 2013
The emerging role of immunosurveillance in dictating metastatic spread in breast cancerClare Y Slaney, Jai Rautela, Belinda S Parker
Cancers|February 25, 2023
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and ChallengesEvan G Pappas, Michael H Kershaw, Clare Y Slaney
Cancer Research|December 6, 2014
Trafficking of T cells into tumorsClare Y Slaney, Michael H Kershaw, Phillip K Darcy
Cancer Discovery|July 18, 2018
CARs versus BiTEs: A Comparison between T Cell-Redirection Strategies for Cancer TreatmentClare Y Slaney, Pin Wang, Phillip K Darcy, et al.
Oncoimmunology|March 14, 2013
The role of Type I interferons in immunoregulation of breast cancer metastasis to the boneClare Y Slaney, Andreas Möller, Paul J Hertzog, et al.
Clinical & Translational Immunology|December 16, 2014
Clinical application of genetically modified T cells in cancer therapyMichael H Kershaw, Jennifer A Westwood, Clare Y Slaney, et al.
Immunotherapy Advances|August 3, 2022
Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancersAaron J Harrison, Xin Du, Bianca von Scheidt, et al.
Immunology and Cell Biology|November 10, 2010
Naïve blood monocytes suppress T-cell function. A possible mechanism for protection from autoimmunityClare Y Slaney, Aras Toker, Anne La Flamme, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2015
Releasing the Brake on Oncolytic Viral TherapyClare Y Slaney, Phillip K Darcy
Cancers|October 31, 2020
Challenges and Opportunities for Effective Cancer ImmunotherapiesClare Y Slaney, Michael H Kershaw
Cancer Research|September 25, 2013
The emerging role of immunosurveillance in dictating metastatic spread in breast cancerClare Y Slaney, Jai Rautela, Belinda S Parker
Cancers|February 25, 2023
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and ChallengesEvan G Pappas, Michael H Kershaw, Clare Y Slaney
Cancer Research|December 6, 2014
Trafficking of T cells into tumorsClare Y Slaney, Michael H Kershaw, Phillip K Darcy
Cancer Discovery|July 18, 2018
CARs versus BiTEs: A Comparison between T Cell-Redirection Strategies for Cancer TreatmentClare Y Slaney, Pin Wang, Phillip K Darcy, et al.
Oncoimmunology|March 14, 2013
The role of Type I interferons in immunoregulation of breast cancer metastasis to the boneClare Y Slaney, Andreas Möller, Paul J Hertzog, et al.
Clinical & Translational Immunology|December 16, 2014
Clinical application of genetically modified T cells in cancer therapyMichael H Kershaw, Jennifer A Westwood, Clare Y Slaney, et al.
Immunotherapy Advances|August 3, 2022
Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancersAaron J Harrison, Xin Du, Bianca von Scheidt, et al.
Immunology and Cell Biology|November 10, 2010
Naïve blood monocytes suppress T-cell function. A possible mechanism for protection from autoimmunityClare Y Slaney, Aras Toker, Anne La Flamme, et al.
Pageof 4